Skip to main content
Signal8

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit LIGHT. This drug is currently undergoing Phase II clinical trials for non-eosinophilic asthma and inflammatory bowel diseases, specifically moderate to severe Crohn's disease and ulcerative colitis. Furthermore, AVTX-002 is also being investigated in Phase III for its potential to treat acute respiratory distress syndrome caused by COVID-19. The company is also advancing AVTX-007, a fully human monoclonal antibody targeting IL-18, which is progressing through Phase I clinical studies for Still's disease, encompassing both adult-onset Still's disease and systemic juvenile idiopathic arthritis. Avalo's late-stage pipeline includes two products addressing rare genetic conditions, both in Phase III clinical trials: AVTX-801, a D-galactose substrate replacement therapy for phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, an L-fucose substrate replacement therapy intended for LADII, medically referred to as SLC35C1-CDG. Established in 2011, the corporation initially operated as Cerecor Inc. before rebranding as Avalo Therapeutics, Inc. in August 2021. Its main operations are situated in Rockville, Maryland.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc.

NASDAQ:AVTXHealthcare
-3.63%$7.17
AH$7.17+0.00%vs close
Mkt Cap$384.53M
Float48.59M
O/S53.63M
Vol
$ Vol
RVOL
Inst Own-
Earnings
Dilution
Financials Summary
Revenue$59K
Net Income-$78.26M
Total Assets$116.46M
Free Cash Flow-$51.46M
Debt & Equity
Debt 3%
Equity 97%
Total Debt$2.43M
Total Equity$83.05M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
  1. 1:240Reverse split
    Dec 29, 2023240 shares → 1
  2. 1:12Reverse split
    Jul 8, 202212 shares → 1
  3. 1:51Reverse split
    Sep 10, 200751 shares → 1
Balance Sheet Details
Assets$116.46M
Liabilities$33.41M
Accounts Receivable$0
Accounts Payable$137K
Inventory$0
PP&E (Net)$460K
Goodwill$10.5M
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$59K$441K$1.92M$18.05M$5.4M$6.7M$6.75M$18.33M$27.81M$1.15M$0$0$0$83K
YoY Growth-86.6%-77.1%-89.3%234.4%-19.4%-0.8%-63.2%-34.1%2312.2%-----
Cost of Revenue$0-$366K$1.28M$3.43M$1.49M$300K-$567K$7.48M$636K$8.24M$24K$9.5M$0$8.48M
Gross Profit$59K$807K$640K$14.62M$3.91M$6.4M$7.32M$10.85M$27.18M-$7.09M-$24K-$9.5M$0-$8.39M
Gross Margin100.0%183.0%33.3%81.0%72.4%95.5%108.4%59.2%97.7%-614.6%----10142.4%
Research and Development$50.08M$52.08M$13.78M$31.31M$59.84M$32.19M$11.76M$5.79M$4.37M$10.15M$6.59M$12.24M$8.91M$8.48M
Selling, General, and Administrative$22.9M$17.24M$10.3M$20.71M$24.66M$19.76M$11.61M$19.2M$8.91M$7.08M$4.42M$4.88M$4.02M$2.1M
Other$0$0$3.91M$38K$1.55M-$45.55M$83K$14K$0$0$0$0$0$0
Total Operating Expenses$72.98M$69.32M$27.99M$52.06M$86.04M$6.4M$23.45M$29.52M$13.29M$17.23M$11.01M$17.12M$12.93M$2.1M
Operating Income (EBIT)-$72.92M-$68.51M-$27.35M-$37.44M-$82.13M$0-$16.14M-$39.31M$13.89M-$16.08M-$11.01M-$17.12M-$12.93M-$10.49M
Operating Margin-123601.7%-15535.6%-1421.6%-207.4%-1521.6%--239.1%-214.5%49.9%-1394.6%----12676.4%
Interest Expense$0$0$3.42M$4.17M$2.39M$0$0$0$24K$464K$793K$1.21M$11K$0
Interest Income$4.35M$3.32M$0$0$0$49K$121K$16K$0$0$0$0$0$1K
Other Income (Expense)-$5.17M$33.5M-$4.18M-$4.19M-$2.41M-$67.18M$147K$55K-$54K-$392K$520K$1.06M-$111K$1K
Income Before Tax (EBT)-$78.09M-$35.02M-$31.53M-$41.63M-$84.55M-$67.18M-$15.99M-$40.09M$13.84M-$16.47M-$10.49M-$16.06M-$13.05M-$10.49M
Income Tax Expense$165K$114K$14K$28K-$196K-$2.79M$280K-$34K$1.97M$364K-$544K$0$111K$0
Net Income-$78.26M-$35.13M-$31.54M-$41.66M-$84.38M-$63.5M-$16.07M-$40.05M$11.87M-$16.47M-$10.49M-$16.06M-$13.05M-$10.49M
Net Income Margin-132642.4%-7965.8%-1639.5%-230.8%-1563.1%-947.9%-238.1%-218.5%42.7%-1428.5%----12674.7%
Supplementary Data
EPS-5.84-4.32-113.58-1062.65-2330.66-2523.77-819.74-3317.281856.88-21.93-16.21-41.61-43.12-199.77
Diluted EPS-5.84-3.26-113.58-1062.65-2330.66-2523.77-819.74-3317.281822.74-21.93-16.21-41.61-43.12-199.77
Weighted Average OS13.40M8.13M277,72739,20236,19125,51119,84912,0746,3923,066773385,845302,55452,509
EBITDA-$77.75M-$34.85M-$23.29M-$37.29M-$80.5M-$45.45M-$13.51M-$13.05M$14.35M-$16.05M-$10.46M-$17.09M-$12.91M-$10.48M
EBITDA Margin-131779.7%-7901.6%-1210.3%-206.6%-1491.2%-678.5%-200.1%-71.2%51.6%-1392.3%----12658.2%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$15.86M$134.55M$7.42M$13.17M$54.59M$18.92M$3.61M$10.65M$2.47M$5.13M$21.16M$11.74M$3.42M$9.52M
Short-Term Investments$82.48M$0$0$0$0$0$7.63M$0$0$0$0$0$0$0
Cash and Short-Term Investments$98.34M$134.55M$7.42M$13.17M$54.59M$18.92M$11.24M$10.65M$2.47M$5.13M$21.16M$11.74M$3.42M$9.52M
Accounts Receivable$0$611K$136K$1.92M$4.8M$4.38M$5.24M$6.08M$2.94M$132K$0$0$0$0
Inventory$0$0$0$20K$38K$3K$21K$1.11M$382K$11K$0$0$0$0
Other Current Assets$6.95M$3.73M$844K$1.3M$51K$38K$515K$9.41M$4.18M$11K$59K$58K$0$430K
Total Current Assets$105.29M$138.89M$8.39M$16.42M$61.84M$26M$17.72M$21.93M$10.99M$5.66M$21.62M$12.16M$4.14M$9.95M
Long-Term Assets
Property, Plant & Equipment Net$460K$1.21M$1.97M$2.41M$2.69M$1.61M$1.45M$587K$45K$43K$35K$39K$66K$57K
Goodwill$10.5M$10.5M$10.5M$14.41M$14.41M$14.41M$14.41M$16.41M$14.29M$0$0$0$0$0
Intangible Assets$0$0$0$0$38K$1.58M$2.43M$31.24M$17.66M$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$82K$131K$63K$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$91K-$131K$0$0$0$0$0
Other Long-Term Assets$210K$131K$131K$131K$1.23M$149K$102K-$91K$131K$173$0$117K$874K-$57K
Total Long-Term Assets$11.17M$11.84M$12.6M$16.95M$18.37M$17.75M$18.38M$48.32M$32.13M$106K$35K$156K$940K$57K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$13K
Total Assets$116.46M$150.73M$20.99M$33.37M$80.21M$43.76M$36.11M$70.25M$43.12M$5.77M$21.66M$12.32M$5.08M$10.02M
Liabilities
Current Liabilities
Accounts Payable$137K$283K$446K$2.88M$3.37M$2.57M$2.08M$1.45M$1.3M$1.01M$678K$931K$1.64M$821K
Short-Term Debt$0$0$0$5.93M$0$0$0$0$0$2.35M$3.21M$1.91M$0$0
Current Income Tax Payable$0$0$0$0$0$0$552K$2.03M$2.26M$0$0$0$0$0
Current Unearned Revenue$0$0$0$88K$0$0$0$2.03M$0$943K$1.89M$975K$0$0
Other Current Liabilities$12.41M$3.24M$3.06M$3.18M$4.32M$4.57M$5.57M$21.14M$8.71M$675K$836K$1.18M$432K$723K
Total Current Liabilities$12.94M$6.96M$4.62M$22.11M$19.89M$15.22M$12.16M$26.22M$11.41M$4.31M$5.85M$4.99M$3.07M$1.54M
Long-Term Liabilities
Long-Term Debt$2M$0$0$13.49M$32.83M$0$0$0$0$0$2.35M$5.31M$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$434K$270K$155K$141K$113K$90K$86K$69K$7K$0$0$0$0$0
Other Long-Term Liabilities$18M$10.47M$8.92M$8.54M$4.3M$3.88M$2.87M$23.06M$3.85M$1.25M$371K$28.35M$19.86M$0
Total Long-Term Liabilities$20.47M$10.74M$9.07M$22.17M$37.24M$3.97M$2.95M$23.13M$3.86M$1.25M$8.57M$33.65M$19.86M$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0-$5.85M$0$0$0
Total Liabilities$33.41M$17.7M$13.69M$44.28M$57.13M$19.19M$15.11M$49.34M$15.26M$5.56M$8.57M$38.65M$22.92M$1.54M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$1K$3K$3K$0$0$21.66B$28.35M$19.86M$19.86M
Common Stock$18K$10K$1K$0$9K$75K$44K$41K$2.69M$9K$9K$650$643$18K
Retained Earnings-$448.52M-$370.26M-$335.13M-$303.82M-$262.17M-$177.79M-$114.29M-$98.22M-$58.17M-$70.04M-$53.56M-$43.07M-$27.02M-$13.97M
Comprehensive Income & Other$68K$0$0$0$0$0$0$0$2.66M$0-$21.66B-$28.35M-$19.86M$0
Other Stockholders' Equity$531.55M$503.29M$342.44M$292.91M$285.24M$202.28M$135.24M$119.09M$83.34M$70.23M$66.64M$16.74M$9.17M$22.43M
Total Equity$83.05M$133.03M$7.3M-$10.91M$23.08M$24.56M$21M$20.91M$27.86M$207K$13.08M-$26.33M-$17.85M$8.48M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$116.46M$150.73M$20.99M$33.37M$80.21M$43.76M$36.11M$70.25M$43.12M$5.77M$21.66M$12.32M$5.08M$10.02M
Supplementary Data
Total Debt$2.43M$568K$537K$19.95M$33.32M$426K$156K$15.38M$0$2.35M$5.56M$7.21M$0$0
Net Debt-$13.43M-$133.98M-$6.88M$6.78M-$21.27M-$18.49M-$3.45M$4.73M-$2.47M-$2.77M-$15.6M-$4.53M-$3.42M-$9.52M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$78.26M-$35.13M-$31.54M-$41.66M-$84.38M-$63.5M-$16.07M-$40.05M$11.87M-$16.47M-$10.49M-$16.06M-$13.05M-$10.49M
Depreciation & Amortization$344K$169K$158K$166K$1.66M$1.84M$3.88M$1.85M$425K$27K$24K$29K$20K$15K
Deferred Income Tax$165K$114K$14K$28K$22K$197K$17K-$17K-$833K-$73K-$1.31M-$1.18M$0$0
Stock-Based Compensation$13.62M$5.85M$3.48M$7.55M$8.17M$6.79M$2.53M$2.43M$1.16M$1.69M$395K$1.09M$749K$588K
Changes in Working Capital:
  Accounts Receivable$0-$475K$1.78M$2.88M$1.12M-$2.79M$6.78M-$223K-$247K-$132K$0$0$0$0
  Inventory$0$0$20K$18K-$35K$18K$533K-$311K-$203K$0$0$0$0$0
  Accounts Payable-$146K-$163K-$2.44M-$487K$796K$99K$1.02M$82K$96K$332K-$269K-$708K$818K$0
  Other Working Capital$3.99M-$4.07M-$8.61M-$2.47M$961K-$1.77M-$10.36M$9.18M-$113K-$245K$1.2M$325K-$174K$0
Total Working Capital Change$3.84M-$4.71M-$9.24M-$60K$2.84M-$4.44M-$2.03M$8.73M-$467K$87K$928K-$383K$644K$0
Other Non-Cash Items$8.83M-$15.35M$6.46M$7.22M$794K$18.57M-$7.47M$23.93M$366K$162K$294K$989K$147K$1.19M
Net Cash from Operating-$51.46M-$49.06M-$30.68M-$26.75M-$70.89M-$40.54M-$19.13M-$3.13M$12.52M-$14.57M-$10.16M-$15.52M-$11.49M-$9.29M
Investing Activities
Capital Expenditures$0$0-$158K-$95K-$113K-$63K-$262K-$564K-$23K-$35K-$20K-$20K-$29K-$12K
Acquisitions$0$356K$0$0$0$11.2M$0$1.43M-$18.89M$0$0$0$0$0
Purchases of Investments-$113.72M$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$31.31M$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$690K$0$25K$0$0$0-$181K-$1K$0$0$0$0$0$0
Net Cash from Investing-$81.72M$356K-$133K-$95K-$113K$11.13M-$443K$865K-$18.91M-$35K-$20K-$20K-$29K-$12K
Financing Activities
Debt Repaid--$21.24M$14.81M-$32.9M-$256K-$2.37M$3.31M$1.81M-$9.64M--
Common Stock Issuance$15.1M$115.63M$46.22M$107K$71.93M$44.45M$12.68M$3.86M$6.34M$2M$23.69M$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$510K$60.22M$67K$0$1.93M$332K$131K$6.55M-$232K-$115K-$2.27M-$365K-$699K$17.71M
Net Cash from Financing$14.59M$175.85M$25.04M-$14.7M$106.76M$44.78M$12.56M$10.4M$3.74M-$1.43M$19.6M$23.86M$5.42M$17.71M
Forex Effect$0$0$0$96K$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$118.59M$127.15M-$5.77M-$41.45M$35.76M$15.38M-$7.02M$8.14M-$2.66M-$16.03M$9.42M$8.32M-$6.1M$8.41M
Supplementary Data
Operating Cash Flow-$51.46M-$49.06M-$30.68M-$26.75M-$70.89M-$40.54M-$19.13M-$3.13M$12.52M-$14.57M-$10.16M-$15.52M-$11.49M-$9.29M
Capital Expenditure$0$0-$158K-$95K-$113K-$63K-$262K-$564K-$23K-$35K-$20K-$20K-$29K-$12K
Free Cash Flow-$51.46M-$49.06M-$30.84M-$26.85M-$71M-$40.6M-$19.4M-$3.69M$12.5M-$14.61M-$10.18M-$15.54M-$11.51M-$9.3M
Cash at Beginning$134.7M$7.55M$13.32M$54.64M$19.11M$3.73M$10.75M$2.61M$5.13M$21.16M$11.74M$3.42M$9.52M$1.11M
Cash at End$16.11M$134.7M$7.55M$13.19M$54.86M$19.11M$3.73M$10.75M$2.47M$5.13M$21.16M$11.74M$3.42M$9.52M